Genetic Testing in Pediatric Neuropsychiatric Disorders
Description of the granted funding
Genetic understanding of psychiatric disorders has greatly advanced, leading to calls for this information to be taken to the clinic. We are performing genome analysis in patients with childhood neuropsychiatric disorders, where large impact de novo mutations are more common, in order to see if genetic testing is a useful tool for the clinic. Furthermore, the underlying symptoms in these disorders can vary over time, but it is not possible to predict which children or what symptoms will improve, meaning that treatment and rehabilitation are given on the current presentation of symptoms. Any single genetic variation is neither necessary nor sufficient in the etiology of these disorders and symptoms. Thus, we are also longitudinally collecting a multitude of different levels of biological data that can vary with time, in order to identify potential biomarkers that could be used to better predict disorder progression and outcome, so that treatment and rehabilitation can be personalized.
Show moreStarting year
2020
End year
2025
Granted funding
Other information
Funding decision number
332583
Fields of science
Genetics, developmental biology, physiology
Research fields
Perinnöllisyystiede
Identified topics
genes, genetics